Comparison of four methods to measure haemoglobin concentrations in whole blood donors (COMPARE): A diagnostic accuracy study

COMPARE Study Group

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

Objective: To compare four haemoglobin measurement methods in whole blood donors. Background: To safeguard donors, blood services measure haemoglobin concentration in advance of each donation. NHS Blood and Transplant's (NHSBT) customary method have been capillary gravimetry (copper sulphate), followed by venous spectrophotometry (HemoCue) for donors failing gravimetry. However, NHSBT's customary method results in 10% of donors being inappropriately bled (ie, with haemoglobin values below the regulatory threshold). Methods: We compared the following four methods in 21 840 blood donors (aged ≥18 years) recruited from 10 NHSBT centres in England, with the Sysmex XN-2000 haematology analyser, the reference standard: (1) NHSBT's customary method; (2) “post donation” approach, that is, estimating current haemoglobin concentration from that measured by a haematology analyser at a donor's most recent prior donation; (3) “portable haemoglobinometry” (using capillary HemoCue); (4) non-invasive spectrometry (using MBR Haemospect or Orsense NMB200). We assessed sensitivity; specificity; proportion who would have been inappropriately bled, or rejected from donation (“deferred”) incorrectly; and test preference. Results: Compared with the reference standard, the methods ranged in test sensitivity from 17.0% (MBR Haemospect) to 79.0% (portable haemoglobinometry) in men, and from 19.0% (MBR Haemospect) to 82.8% (portable haemoglobinometry) in women. For specificity, the methods ranged from 87.2% (MBR Haemospect) to 99.9% (NHSBT's customary method) in men, and from 74.1% (Orsense NMB200) to 99.8% (NHSBT's customary method) in women. The proportion of donors who would have been inappropriately bled ranged from 2.2% in men for portable haemoglobinometry to 18.9% in women for MBR Haemospect. The proportion of donors who would have been deferred incorrectly with haemoglobin concentration above the minimum threshold ranged from 0.1% in men for NHSBT's customary method to 20.3% in women for OrSense. Most donors preferred non-invasive spectrometry. Conclusion: In the largest study reporting head-to-head comparisons of four methods to measure haemoglobin prior to blood donation, our results support replacement of NHSBT's customary method with portable haemoglobinometry.

Original languageEnglish
Pages (from-to)94-103
Number of pages10
JournalTransfusion Medicine
Volume31
Issue number2
DOIs
Publication statusPublished - Apr 2021
Externally publishedYes

Bibliographical note

Funding Information:
This work was supported by Health Data Research UK, which is funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation and Wellcome.

Funding Information:
Participants in the COMPARE study were recruited with the active collaboration of NHS Blood and Transplant (NHSBT) England ( www.nhsbt.nhs.uk ). Funding was provided by NHSBT and the NIHR Blood and Transplant Research Unit (BTRU) in Donor Health and Genomics (NIHR BTRU‐2014–10024). DNA extraction and genotyping were co‐funded by the NIHR BTRU and the NIHR BioResource ( http://bioresource.nihr.ac.uk ). The academic coordinating centre for COMPARE was supported by core funding from: NIHR BTRU, UK Medical Research Council (MR/L003120/1), British Heart Foundation (RG/13/13/30194; RG/18/13/33946) and the NIHR [Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust]. The academic coordinating centre would like to thank blood donor centre staff and blood donors for participating in the COMPARE study. 1

Funding Information:
John Danesh reports grants, personal fees and non‐financial support from Merck Sharp & Dohme (MSD), grants, personal fees and non‐financial support from Novartis, grants from Pfizer and grants from AstraZeneca outside the submitted work.

Publisher Copyright:
© 2020 The Authors. Transfusion Medicine published by John Wiley & Sons Ltd on behalf of British Blood Transfusion Society.

Keywords

  • gravimetry
  • haemoglobin screening
  • HemoCue
  • inappropriate bleeding
  • inappropriate deferral
  • non-invasive haemoglobin measurement
  • whole blood donor

Fingerprint

Dive into the research topics of 'Comparison of four methods to measure haemoglobin concentrations in whole blood donors (COMPARE): A diagnostic accuracy study'. Together they form a unique fingerprint.

Cite this